INCY — INCYTE CORP catalysts

Name: Bio Catalyst Calendar — source-anchored biotech/pharma catalyst dates
Creator: Bio Catalyst Calendar
License: https://www.usa.gov/government-works

4 verified catalyst event(s) for INCYTE CORP (ticker INCY). Each is linked to its official source. Verified as of 2026-11-04.

Next verified catalyst

2026-11-05 — Rollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Pr · official source ↗

Upcoming

Date	Event	Company	Drug	Official source & verification
2026-11-05 in 1d ESTIMATED	READOUT Rollover Study to Provide Continued Treatment for Participants With B-Cell Malig Phase 2 · B-Cell Malignancies	INCY INCYTE CORP	Parsaclisib, parsaclisib + itacitinib, p	ClinicalTrials.gov ↗ ✓ Source-checked 2026-11-04 Sponsor-projected date — can change
2026-11-20 in 16d ESTIMATED	READOUT A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participant Phase 2 · Moderate to Severe Asthma	INCY INCYTE CORP	povorcitinib, ICS-LABA	ClinicalTrials.gov ↗ ✓ Source-checked 2026-11-04 Sponsor-projected date — can change
2026-12-26 in 2mo ESTIMATED	READOUT A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Partici Phase 3 · Hidradenitis Suppurativa (HS)	INCY INCYTE CORP	Povorcitinib	ClinicalTrials.gov ↗ ✓ Source-checked 2026-11-04 Sponsor-projected date — can change
2027-01-06 in 2mo ESTIMATED	READOUT A Ph1b/2 Study of Axatilimab Monotherapy in Chinese Participants With Recurrent Phase 1/2 · Chronic Graft-versus-host-disease	INCY INCYTE CORP	INCA034176	ClinicalTrials.gov ↗ ✓ Source-checked 2026-11-04 Sponsor-projected date — can change